BioAmber Inc (fka BIOAQ)

[MadScholar1]

We've learned that KKR now owns LCY Biosciences. De facto KKR owns BioAmber's technology. Being a company whose holding earned $244B last year with a value of $700B, it would seem strange that Mr Eno would sell off all BioAmber's assets for $4.34M. Pretty good catch for KKR. Of course ... there's gotta be a catch. Especially with BioAmber, Inc., again popping up now.